Floris Grasmeijer

1.1k total citations
31 papers, 831 citations indexed

About

Floris Grasmeijer is a scholar working on Pulmonary and Respiratory Medicine, Biomedical Engineering and Pharmaceutical Science. According to data from OpenAlex, Floris Grasmeijer has authored 31 papers receiving a total of 831 indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Pulmonary and Respiratory Medicine, 6 papers in Biomedical Engineering and 4 papers in Pharmaceutical Science. Recurrent topics in Floris Grasmeijer's work include Inhalation and Respiratory Drug Delivery (28 papers), Cystic Fibrosis Research Advances (6 papers) and Advanced Chemical Sensor Technologies (4 papers). Floris Grasmeijer is often cited by papers focused on Inhalation and Respiratory Drug Delivery (28 papers), Cystic Fibrosis Research Advances (6 papers) and Advanced Chemical Sensor Technologies (4 papers). Floris Grasmeijer collaborates with scholars based in Netherlands, Italy and Germany. Floris Grasmeijer's co-authors include Henderik W. Frijlink, Paul Hagedoorn, Anne H. de Boer, Marcel Hoppentocht, Francesca Buttini, Onno W. Akkerman, Anthony J. Hickey, Niels Grasmeijer, Wouter L.J. Hinrichs and Gerard H. Koppelman and has published in prestigious journals such as PLoS ONE, European Respiratory Journal and International Journal of Pharmaceutics.

In The Last Decade

Floris Grasmeijer

31 papers receiving 807 citations

Peers

Countries citing papers authored by Floris Grasmeijer

Since Specialization

Citations

This map shows the geographic impact of Floris Grasmeijer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Floris Grasmeijer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Floris Grasmeijer more than expected).

Fields of papers citing papers by Floris Grasmeijer

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Floris Grasmeijer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Floris Grasmeijer. The network helps show where Floris Grasmeijer may publish in the future.

Co-authorship network of co-authors of Floris Grasmeijer

This figure shows the co-authorship network connecting the top 25 collaborators of Floris Grasmeijer. A scholar is included among the top collaborators of Floris Grasmeijer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Floris Grasmeijer. Floris Grasmeijer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Tolerability and Pharmacokinetic Evaluation of Inhaled Dry Powder Tobramycin in Children with Cystic Fibrosis 2025 ·Pharmaceutics ·(unknown), Paul Hagedoorn, Bart L. Rottier, Floris Grasmeijer, Henderik W. Frijlink, Matthijs van Luin, (unknown), Peter Merkus, Daan J. Touw, Onno W. Akkerman, Gerard H. Koppelman	1
2	Dry powder inhalation, part 1: ancient history and precursors to modern dry powder inhalers 2022 ·Expert Opinion on Drug Delivery ·Anne H. de Boer, Paul Hagedoorn, Floris Grasmeijer	5
3	Tolerability and pharmacokinetic evaluation of inhaled dry powder hydroxychloroquine in healthy volunteers 2022 ·PLoS ONE ·(unknown), Paul Hagedoorn, Marieke G. G. Sturkenboom, Floris Grasmeijer, Mathieu S. Bolhuis, (unknown), Huib A.M. Kerstjens, Henderik W. Frijlink, Onno W. Akkerman	12
4	Dry powder inhalation, part 2: the present and future 2022 ·Expert Opinion on Drug Delivery ·Anne H. de Boer, Paul Hagedoorn, Floris Grasmeijer	11
5	Natural and bioinspired excipients for dry powder inhalation formulations 2021 ·Current Opinion in Colloid & Interface Science ·(unknown), (unknown), Wouter L.J. Hinrichs, Henderik W. Frijlink, Floris Grasmeijer	40
6	Colistin dry powder inhalation with the Twincer™: An effective and more patient friendly alternative to nebulization 2020 ·PLoS ONE ·(unknown), Floris Grasmeijer, Huib A.M. Kerstjens, Henderik W. Frijlink, C. H. van der Vaart, Judith M. Vonk, Paul Hagedoorn, Bart L. Rottier, Gerard H. Koppelman, Onno W. Akkerman	12
7	A comparative analysis of changes in pMDI drug dose delivery before and after detergent coating using five antistatic valved holding chambers 2019 ·The Journal of Allergy and Clinical Immunology In Practice ·Paul Hagedoorn, (unknown), Henderik W. Frijlink, Floris Grasmeijer	12
8	Challenges for pulmonary delivery of high powder doses 2018 ·International Journal of Pharmaceutics ·(unknown), Paul Hagedoorn, Anne H. de Boer, Henderik W. Frijlink, Floris Grasmeijer	60
9	Characterisation of jet-milled and spray dried isoniazid for pulmonary administration 2017 ·Journal of Aerosol Medicine and Pulmonary Drug Delivery ·(unknown), Floris Grasmeijer, Paul Hagedoorn, Henderik W. Frijlink	1
10	Can Patients with Parkinson’s Disease Use Dry Powder Inhalers during Off Periods? 2015 ·PLoS ONE ·(unknown), (unknown), (unknown), Floris Grasmeijer, Paul Hagedoorn, (unknown), Henderik W. Frijlink, Anne H. de Boer	14
11	Recent advances in the fundamental understanding of adhesive mixtures for inhalation 2015 ·Current Pharmaceutical Design ·Floris Grasmeijer, Niels Grasmeijer, Paul Hagedoorn, Henderik W. Frijlink, Anne H. de Boer	40
12	A levodopa dry powder inhaler for the treatment of Parkinson’s disease patients in off periods 2015 ·European Journal of Pharmaceutics and Biopharmaceutics ·(unknown), Floris Grasmeijer, Paul Hagedoorn, (unknown), Henderik W. Frijlink, Anne H. de Boer	33
13	THE INTERPLAY BETWEEN VARIABLES IN THE FORMULATION AND DISPERSION OF ADHESIVE MIXTURES FOR INHALATION 2014 ·Journal of Aerosol Medicine and Pulmonary Drug Delivery ·Floris Grasmeijer, Paul Hagedoorn, Henderik W. Frijlink, Anne H. de Boer	1
14	New Mechanisms to Explain the Effects of Added Lactose Fines on the Dispersion Performance of Adhesive Mixtures for Inhalation 2014 ·PLoS ONE ·Floris Grasmeijer, (unknown), (unknown), Paul Hagedoorn, Anthony J. Hickey, Henderik W. Frijlink, Anne H. de Boer	61
15	The dispersion behaviour of dry powder inhalation formulations cannot be assessed at a single inhalation flow rate 2014 ·International Journal of Pharmaceutics ·Floris Grasmeijer, Anne H. de Boer	6
16	The influence of mixing time and intensity on blend homogeneity and dispersion performance 2013 ·Journal of Aerosol Medicine and Pulmonary Drug Delivery ·(unknown), Floris Grasmeijer, (unknown), (unknown), (unknown), Hartwig Steckel	3
17	Comparative in vitro performance of the new drug aclidinium in a novel multidose dry powder inhaler 2013 ·European Respiratory Journal ·Doetie Gjaltema, Paul Hagedoorn, Floris Grasmeijer, (unknown), Henderik W. Frijlink, Anne H. de Boer	7
18	Mixing Time Effects on the Dispersion Performance of Adhesive Mixtures for Inhalation 2013 ·PLoS ONE ·Floris Grasmeijer, Paul Hagedoorn, Henderik W. Frijlink, (unknown)	31
19	Drug Content Effects on the Dispersion Performance of Adhesive Mixtures for Inhalation 2013 ·PLoS ONE ·Floris Grasmeijer, Paul Hagedoorn, Henderik W. Frijlink, Anne H. de Boer	32
20	Characterisation of high dose aerosols from dry powder inhalers 2012 ·International Journal of Pharmaceutics ·Floris Grasmeijer, Paul Hagedoorn, Henderik W. Frijlink, Anne H. de Boer	16

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact